Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare FSS Plan Would Cost VA Over $500 Mil., Rep. Stearns Says

Executive Summary

Extending federal supply schedule prices for pharmaceuticals to the Medicare population could cost the Department of Veterans Affairs half a billion dollars annually, Rep. Stearns (R-Fla.) told a House Commerce/Health & Environment Subcommittee hearing on seniors' access to prescription drugs Oct. 4.

You may also be interested in...



VA Drug Coverage Expansion Proposed; Fallback If Medicare Rx Fails?

A proposal by Senate Veterans Affairs Committee Chairman Arlen Specter (R-Pa.) to offer all Medicare-eligible veterans access to VA drug prices is the latest possible senior drug coverage fallback bill to be introduced in Congress

VA Drug Coverage Expansion Proposed; Fallback If Medicare Rx Fails?

A proposal by Senate Veterans Affairs Committee Chairman Arlen Specter (R-Pa.) to offer all Medicare-eligible veterans access to VA drug prices is the latest possible senior drug coverage fallback bill to be introduced in Congress

Pfizer Adds Urgency To Call For Drug Benefit: 107th Congress Is Well-Aligned

Pfizer is pressing for Congressional action on expanded drug benefits for the elderly in its early meetings with the Republican health committee leaders in the 107th Congress.

Related Content

UsernamePublicRestriction

Register

PS034970

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel